Drug Eluting Stent News and Research

RSS
A drug-eluting stent (DES) is a coronary stent (a scaffold) placed into narrowed, diseased coronary arteries that slowly releases a drug to block cell proliferation. This prevents fibrosis that, together with clots (thrombus), could otherwise block the stented artery, a process called restenosis.
Radial approach superior than femoral one for coronary angiography and PCI for ACS patients

Radial approach superior than femoral one for coronary angiography and PCI for ACS patients

ESC Congress to highlight results from global trials in six press conferences

ESC Congress to highlight results from global trials in six press conferences

Mount Sinai launches clinical trial to test effectiveness of ticagrelor drug in treating coronary stent patients

Mount Sinai launches clinical trial to test effectiveness of ticagrelor drug in treating coronary stent patients

Biosensors’ Q1 FY16 revenue reduces US$67.0M compared to US$80.2M in Q1 FY15

Biosensors’ Q1 FY16 revenue reduces US$67.0M compared to US$80.2M in Q1 FY15

Survey: 52% of acute coronary syndrome patients don't take their prescribed OAP therapy

Survey: 52% of acute coronary syndrome patients don't take their prescribed OAP therapy

Cardiac catheterization performed through wrist can reduce bleeding, lower mortality

Cardiac catheterization performed through wrist can reduce bleeding, lower mortality

Extended dual antiplatelet therapy after DES implantation increases mortality

Extended dual antiplatelet therapy after DES implantation increases mortality

Patients with multiple narrowed arteries have better outcomes with CABG than with PCI

Patients with multiple narrowed arteries have better outcomes with CABG than with PCI

Cook Medical receives CE Mark for new thumbwheel deployment system for Zilver PTX drug-eluting peripheral stent

Cook Medical receives CE Mark for new thumbwheel deployment system for Zilver PTX drug-eluting peripheral stent

Clinical trial results of drug-eluting stent for peripheral arterial disease presented at LINC 2015

Clinical trial results of drug-eluting stent for peripheral arterial disease presented at LINC 2015

Boston Scientific starts PLATINUM Diversity trial to evaluate Promus PREMIER Stent System

Boston Scientific starts PLATINUM Diversity trial to evaluate Promus PREMIER Stent System

Abbott announces initiation of ABSORB IV heart stent clinical trial

Abbott announces initiation of ABSORB IV heart stent clinical trial

Drug-eluting peripheral stent from Cook Medical selected as a top 10 game-changing health technology for 2014

Drug-eluting peripheral stent from Cook Medical selected as a top 10 game-changing health technology for 2014

Zilver® PTX® drug-eluting stent from Cook Medical receives positive one-year follow-up results

Zilver® PTX® drug-eluting stent from Cook Medical receives positive one-year follow-up results

Micell Technologies presents DESSOLVE I and II trial data at EuroPCR conference

Micell Technologies presents DESSOLVE I and II trial data at EuroPCR conference

BIOTRONIK ProMRI ICD trial expansion achieves FDA approval

BIOTRONIK ProMRI ICD trial expansion achieves FDA approval

BIOTRONIK's Entovis pacemaker system gets FDA approval

BIOTRONIK's Entovis pacemaker system gets FDA approval

Boston Scientific presents new data on cardiology-related clinical trials at ACC 2014

Boston Scientific presents new data on cardiology-related clinical trials at ACC 2014

FDA approves expansion of BIOTRONIK's ongoing ProMRI trial

FDA approves expansion of BIOTRONIK's ongoing ProMRI trial

Sanford Hospital starts clinical trial to study dissolving device in patients with CAD

Sanford Hospital starts clinical trial to study dissolving device in patients with CAD